>Title;Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation.
>Date;02/10/2017
>Journal;J Allergy Clin Immunol
>Country;United States
>Conflict;NA
